Brazikumab, CAS 1610353-18-8

Product Description: Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Currò D, et, al. Frontiers in Drug Research and Development for Inflammatory Bowel Disease. Front Pharmacol. 2017 Jun 23;8:400./[2]Al-Bawardy B, et, al. Novel and Emerging Therapies for Inflammatory Bowel Disease. Front Pharmacol. 2021 Apr 14;12:651415.

CAS Number: 1610353-18-8

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• SKU: MEXHY-P99485-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99485-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated